Quantitative bone scintigraphy in patients with hyperparathyroidism.
Laboratory tests, including the determination of parathormone in serum, and x-ray examinations are often of limited value in diagnosing hyperparathyroidism (HPT). In this study, bone scintigraphy was carried out in 15 patients with proven HPT (primary and secondary in patients with chronic renal disease) and 25 normal subjects, to evaluate quantitatively increased bone metabolism. The count density ratios bone to soft tissue (D/S-index) were calculated. In normal, this D/S index averaged 3.66 +/- 0.94 and was significantly (p less than 0.001) different to that of HPT-patients averaging 6.37 +/- 1.64. The quantitative evaluation shows a sensitivity of 73%, a specificity of 100% and an accuracy of 90% for detecting HPT (based on the sample values). Discriminant analysis can be applied to calculate the probability of the presence of HPT (primary and secondary) as a function of the measured D/S index.
D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging; D005269:Femur / Q000000981:diagnostic imaging; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013223:Statistics as Topic; D013848:Thigh / Q000000981:diagnostic imaging